Distal deletion 3p syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1620OMIM:613792Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Distal deletion 3p syndrome (also known as 3p deletion syndrome, monosomy 3p, or chromosome 3p deletion syndrome) is a rare chromosomal disorder caused by a partial deletion of the short arm (p) of chromosome 3, typically involving the 3p25-pter region. The condition is usually identified at birth or in early infancy due to characteristic features including intellectual disability, growth retardation, microcephaly, and distinctive craniofacial dysmorphism. Facial features commonly include a long philtrum, micrognathia (small jaw), ptosis (drooping eyelids), telecanthus or hypertelorism (widely spaced eyes), and a flat nasal bridge. Many affected individuals also have low-set or malformed ears. The syndrome affects multiple body systems. Congenital heart defects are frequently reported and may include atrial or ventricular septal defects and other structural cardiac anomalies. Gastrointestinal abnormalities, renal malformations, and skeletal anomalies such as polydactyly or clinodactyly may also occur. Hypotonia (low muscle tone) is common in infancy and can contribute to feeding difficulties and delayed motor development. Developmental delay and intellectual disability range from mild to severe, and speech and language development are often significantly affected. Some patients may also experience seizures. There is no cure for distal deletion 3p syndrome, and management is supportive and symptom-based. Treatment typically involves a multidisciplinary approach including early intervention programs, speech therapy, physical therapy, occupational therapy, and special education services. Cardiac defects may require surgical correction. Regular monitoring by cardiology, nephrology, and neurology specialists is recommended depending on the individual's clinical presentation. Genetic counseling is advised for affected families to discuss recurrence risk and the nature of the chromosomal abnormality.

Also known as:

Clinical phenotype terms— hover any for plain English:

Atrioventricular canal defectHP:0006695
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Distal deletion 3p syndrome.

View clinical trials →

No actively recruiting trials found for Distal deletion 3p syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Distal deletion 3p syndrome community →

No specialists are currently listed for Distal deletion 3p syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Distal deletion 3p syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Distal deletion 3p syndromeForum →

No community posts yet. Be the first to share your experience with Distal deletion 3p syndrome.

Start the conversation →

Latest news about Distal deletion 3p syndrome

No recent news articles for Distal deletion 3p syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Distal deletion 3p syndrome

What is Distal deletion 3p syndrome?

Distal deletion 3p syndrome (also known as 3p deletion syndrome, monosomy 3p, or chromosome 3p deletion syndrome) is a rare chromosomal disorder caused by a partial deletion of the short arm (p) of chromosome 3, typically involving the 3p25-pter region. The condition is usually identified at birth or in early infancy due to characteristic features including intellectual disability, growth retardation, microcephaly, and distinctive craniofacial dysmorphism. Facial features commonly include a long philtrum, micrognathia (small jaw), ptosis (drooping eyelids), telecanthus or hypertelorism (widely

At what age does Distal deletion 3p syndrome typically begin?

Typical onset of Distal deletion 3p syndrome is neonatal. Age of onset can vary across affected individuals.